{"id":892548,"title":"Summary of the NACI Statement: Updated guidance on HPV vaccines, CCDR 50(12) - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T01:56:42.351000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-12-december-2024/summary-naci-statement-updated-guidance-hpv-vaccines.html","snippet":"Summary of the NACI Statement: Updated guidance on HPV vaccines Download this article as a PDF (88 KB) Published by: The Public Health Agency of Canada Issue: CCDR Volume 50-12, December 2024: Tuberculosis Date published: December 2024 ISSN: 1481-8531 Subscribe to CCDR…","rawSnapshotUrl":"/api/snapshots/raw/892548","browseUrl":"https://replay.healtharchive.ca/job-7/20260306015642/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-12-december-2024/summary-naci-statement-updated-guidance-hpv-vaccines.html#ha_snapshot=892548","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}